MAIA Biotechnology (NYSEAMERICAN:MAIA – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.32) by $0.21, Zacks reports.
MAIA Biotechnology Price Performance
MAIA Biotechnology stock traded down $0.20 during midday trading on Thursday, hitting $2.19. 128,765 shares of the company’s stock were exchanged, compared to its average volume of 286,300. MAIA Biotechnology has a 12 month low of $0.82 and a 12 month high of $5.99. The stock has a market cap of $52.36 million, a price-to-earnings ratio of -1.57 and a beta of 0.32.
Insider Transactions at MAIA Biotechnology
In other MAIA Biotechnology news, Director Cristian Luput acquired 22,133 shares of MAIA Biotechnology stock in a transaction that occurred on Friday, November 1st. The stock was bought at an average price of $2.51 per share, with a total value of $55,553.83. Following the completion of the purchase, the director now directly owns 389,483 shares of the company’s stock, valued at approximately $977,602.33. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 36.98% of the company’s stock.
MAIA Biotechnology Company Profile
MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.
See Also
- Five stocks we like better than MAIA Biotechnology
- Stock Average Calculator
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Why Are Stock Sectors Important to Successful Investing?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Financial Services Stocks Investing
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for MAIA Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAIA Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.